natgillin/translations-raw huggingface dataset:
• Avoid knocking or pulling the on-body injector. 
• Izogibajte se temu, da bi z injektorjem kam zadeli ali bi ga potegnili.
Injection site reactions, including injection site erythaema (uncommon) as well as injection site pain (common) have occurred on initial or subsequent treatment with pegfilgrastim. 
Med začetnim ali nadaljnjim zdravljenjem s pegfilgrastimom so se pojavile reakcije na mestu injiciranja, vključno z eritemom na mestu injiciranja (občasno) kot tudi bolečino na mestu injiciranja (pogosto).
Talk to your doctor, pharmacist or nurse before using Neulasta: 
Pred začetkom uporabe zdravila Neulasta se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro:
Glomerulonephritis has been reported in patients receiving filgrastim and pegfilgrastim. 
Pri bolnikih, ki so dobivali filgrastim ali pegfilgrastim, so poročali o glomerulonefritisu.
With the exception of the youngest age group (0-5 years), the mean AUC in paediatric subjects appeared similar to that for adult patients with high-risk stage II-IV breast cancer and receiving 100 mcg/kg pegfilgrastim after the completion of doxorubicin/docetaxel (see sections 4.8 and 5.1). 
do IV. stadiju, ki so dobile 100 µg/kg pegfilgrastima po dokončanju doksorubicina/docetaksela (glejte poglavji 4.8 in 5.1).
Neulasta 6 mg solution for injection in pre-filled syringe 
Neulasta 6 mg raztopina za injiciranje v napolnjeni injekcijski brizgi
Metabolism and nutrition disorders 
Trombocitopenija in anemija
Solution for injection in a single use pre-filled syringe (0.6 mL). 
Raztopina za injiciranje v napolnjeni injekcijski brizgi (0,6 ml) za enkratno uporabo.
Using Neulasta with the on-body injector 
Uporaba zdravila Neulasta z injektorjem, ki se pritrdi na telo (injektor)
The safety and efficacy of Neulasta have not been evaluated in patients receiving chemotherapy associated with delayed myelosuppression e.g. nitrosoureas. 
Pri bolnikih, ki dobivajo kemoterapijo, povezano z odloženo mielosupresijo, na primer nitrozouree, varnosti in učinkovitosti zdravila Neulasta niso ovrednotili.
OUTER CARTON FOR UNBLISTERED SYRINGE 
OZNAKA BRIZGE V OVOJNINI BREZ PRETISNEGA OMOTA
Neulasta 6 mg solution for injection with on-body injector pegfilgrastim 
Neulasta 6 mg raztopina za injiciranje z injektorjem, ki se pritrdi na telo (injektor) pegfilgrastim
Stop using Neulasta and seek medical attention immediately if you notice any of the symptoms described in section 4. 
Če opazite katerega od simptomov, opisanih v poglavju 4, prenehajte uporabljati zdravilo Neulasta in nemudoma poiščite zdravniško pomoč.
Syringe label Used syringe barrel 
Nalepka brizge Uporabljeni valj brizge
BLISTER PACK FOR SYRINGE TO BE USED WITH ON-BODY INJECTOR 
PRETISNI OMOT ZA BRIZGO, KI SE MORA UPORABITI Z INJEKTORJEM, KI SE PRITRDI NA TELO
The on-body injector must only be used with the co-packed pre-filled syringe. 
Injektor je dovoljeno uporabiti le z napolnjeno injekcijski brizgo, priloženo v pakiranju.
Neulasta 6 mg solution for injection pegfilgrastim 
Neulasta 6 mg raztopina za injiciranje pegfilgrastim
Acute Respiratory Distress 
Neželene reakcije na pljučih
Do not reuse the pre-filled syringe. 
Napolnjene injekcijske brizge ne smete uporabiti znova.
Sodium acetate* Sorbitol (E420) Polysorbate 20 
6.1 Seznam pomožnih snovi natrijev acetat* sorbitol (E420) polisorbat 20 voda za injekcije
If there is blood, press a cotton ball or gauze pad on your injection site. 
Če opazite kri, na mesto injiciranja pritisnite s kosmom vate ali zložencem gaze.
Cannula window 
Okence kanile
Do not shake the pre-filled syringe. 
Napolnjene injekcijske brizge ne stresajte.
• application site reactions which may include redness, bleeding, bruising, pain and discomfort have been seen with the on-body injector. 
Med uporabo injektorja so poročali o reakcijah na mestu namestitve (vključno s krvavitvijo, bolečino, nelagodjem, podplutbo in eritemom).
Back of upper arm 
nadlaket trebuh zgornji del stegna
CLINICAL PARTICULARS 
Sestavni deli
Each pre-filled syringe contains 6 mg of pegfilgrastim* in 0.6 mL solution for injection. 
KAKOVOSTNA IN KOLIČINSKA SESTAVA Ena napolnjena injekcijska brizga vsebuje 6 mg pegfilgrastima* v 0,6 ml raztopine za injiciranje.
• If there is blood, press a clean cotton ball or gauze pad on the application site. 
• Če opazite kri, na mesto dajanja zdravila pritisnite s kosmom vate ali zložencem iz gaze.
Grab the pre-filled syringe safety guard to remove the pre-filled syringe from the tray. 
Napolnjeno injekcijsko brizgo vzemite iz podloge tako, da jo primete za njen varnostni ščitnik.
Used needle 
Uporabljena igla
How to store Neulasta 
Shranjevanje zdravila Neulasta
OUTER CARTON FOR BLISTERED SYRINGE 
ŠKATLA ZA BRIZGO V PRETISNEM OMOTU
UNBLISTERED SYRINGE LABEL 
Samoinjiciranje zdravila Neulasta
Belly 
Bat
Common side effects (may affect up to 1 in 10 people): 
Pogosti neželeni učinki (pojavijo se lahko pri največ 1 od 10 bolnikov):
You should check with your doctor or pharmacist if you are unsure. 
Če ste negotovi, se posvetujte z zdravnikom ali farmacevtom.
London, 20 August 2009 Doc. 
London, 20. avgust 2009 Sklic dok.
Ref. EMEA/505188/2009 EMEA/H/C/1069 
: EMEA/702709/2009 EMEA/H/C/1069
The summary of opinion of the Committee for Orphan Medicinal Products for Bosatria is available here. 
Povzetek mnenja Odbora za zdravila sirote o zdravilu Bosatria je na voljo tukaj.
The main measure of effectiveness was the number of patients who could have their daily prednisone dose reduced to 10 mg or lower for a period of eight weeks. 
Glavno merilo učinkovitosti je bilo število bolnikov, pri katerih so lahko dnevni odmerek prednizona za 8 tednov zmanjšali na 10 mg ali manj.
Questions and answers on the withdrawal of the marketing authorisation application for Bosatria mepolizumab 
Vprašanja in odgovori v zvezi z umikom vloge za dovoljenje za promet z zdravilom Bosatria mepolizumab
Following the CHMP's opinion, it usually takes around two months for the European Commission to issue a decision on this opinion. 
Potem ko CHMP izda svoje mnenje, navadno traja približno dva meseca, preden Evropska komisija dovoljenje odobri.
The effects of Bosatria were first tested in experimental models before being studied in humans. 
Učinki zdravila Bosatria so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
What are the consequences of the withdrawal for patients in clinical trials or compassionate use programmes using Bosatria? 
Kakšne so posledice umika za bolnike, ki sodelujejo v kliničnih preskušanjih ali programih sočutne uporabe zdravila Bosatria?
A monoclonal antibody is an antibody (a type of protein) that has been designed to recognise and attach to a specific structure (called an antigen) that is found in the body. 
Monoklonsko protitelo je protitelo (vrsta beljakovine), ki prepoznava in se veže na specifično strukturo (ki ji pravimo antigen) v telesu.
During the study the patients received either Bosatria or placebo while the amount of prednisone they received was gradually reduced. 
Med študijo so bolniki prejeli bodisi zdravilo Bosatria bodisi placebo, medtem pa so postopoma zmanjšali količino prejetega prednizona.
This is a disease in which eosinophils (a type of white blood cell) start growing out of control, they accumulate in the tissues of many organs, and can cause damage to organs such as the heart, liver and lungs. 
Pri tej bolezni ni več nadzora nad nastajanjem eozinofilcev (vrste belih krvnih celic), ki se kopičijo v tkivih številnih organov in lahko poškodujejo organe, kot so srce, jetra in pljuča.
The company informed the CHMP that Bosatria will continue to be made available for patients in the open-label extension study and compassionate use programmes. 
Družba je obvestila CHMP, da bo zdravilo Bosatria še naprej na razpolago bolnikom v odprtem podaljšku študije ter v programih sočutne uporabe.
It contains the active substance mepolizumab. 
Vsebuje zdravilno učinkovino mepolizumab.
The CHMP was of the opinion that the main study did not provide sufficient evidence to show that Bosatria was effective in reducing the need for corticosteroid treatment. 
CHMP je menil, da v glavni študiji ni bilo zadostnih dokazov, s katerimi bi dokazali, da je zdravilo Bosatria učinkovito pri zmanjševanju potrebe po zdravljenju s kortikosteroidi.
The CHMP was also concerned that the method used by the company to quantify the different forms of the active substance in the medicine was not appropriate. 
CHMP je imel tudi zadržke glede ustreznosti metode, ki jo je družba uporabljala za določitev količine različnih oblik zdravilne učinkovine v zdravilu.
In one main study involving 85 adults with hypereosinophilic syndrome, Bosatria was compared with placebo (a dummy treatment). 
V eni glavni študiji, v katero je bilo vključenih 85 odraslih bolnikov s hipereozinofilnim sindromom, so zdravilo Bosatria primerjali s placebom (zdravilom brez zdravilne učinkovine).
Mepolizumab has been designed to attach to a chemical messenger called interleukin 5 (IL-5), which is involved in the growth of eosinophils. 
Mepolizumab je izdelan tako, da se veže na sporočilno kemikalijo, imenovano interlevkin 5 (IL-5), ki sodeluje pri nastajanju eozinofilcev.
All patients lacked the FIP1L1-PDGRF fusion gene and were receiving treatment with prednisone (a corticosteroid) that was helping to stabilise their symptoms. 
Vsem bolnikom je manjkal fuzijski gen FIP1L1-PDGRF in so se zdravili s prednizonom (kortikosteroidom), ki je pripomogel k stabilizaciji simptomov.
What is Bosatria? 
Kaj je zdravilo Bosatria?
Bosatria was designated an ‘orphan medicine' (a medicine to be used in rare diseases) on 29 July 2004 for the treatment of hypereosinophilic syndrome. 
Zdravilo Bosatria je bilo dne 29. julija 2004 določeno kot „zdravilo sirota“ (zdravilo, ki se uporablja pri redkih boleznih) za zdravljenje hipereozinofilnega sindroma.
The application was at day 180 when the company withdrew. 
Družba je vlogo umaknila na 180. dan postopka.
What was Bosatria expected to be used for? 
Za kaj naj bi se zdravilo Bosatria uporabljalo?
Bosatria was expected to be used to treat adults with hypereosinophilic syndrome. 
Zdravilo Bosatria naj bi se uporabljajo za zdravljenje odraslih bolnikov s hipereozinofilnim sindromom.
The active substance in Bosatria, mepolizumab, is a monoclonal antibody. 
Zdravilna učinkovina zdravila Bosatria je mepolizumab, ki je monoklonsko protitelo.
By attaching to IL-5, mepolizumab was expected to reduce the accumulation of eosinophils in the blood, thereby relieving the symptoms of patients with hypereosinophilic syndrome. 
Mepolizumab naj bi z vezavo na IL-5 zmanjšal kopičenje eozinofilcev v krvi in s tem zmanjšal simptome bolnikov s hipereozinofilnim sindromom.
Bosatria is a powder that is made up into a solution for infusion (drip into a vein). 
Zdravilo Bosatria je prašek za pripravo raztopine za infundiranje (kapalne infuzije v veno).
On 28 July 2009, Glaxo Group Limited officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Bosatria, for the treatment of adults with hypereosinophilic syndrome to reduce or eliminate the need for corticosteroid therapy and to reduce blood eosinophil counts. 
Družba Glaxo Group Limited je dne 28. julija 2009 uradno obvestila Odbor za zdravila za uporabo v humani medicini (CHMP), da želi umakniti vlogo za dovoljenje za promet z zdravilom Bosatria, namenjenim zdravljenju odraslih bolnikov s hipereozinofilnim sindromom za zmanjšanje ali odpravo potrebe po zdravljenju s kortikosteroidi in zmanjšanje števila eozinofilcev v krvi.
How is Bosatria expected to work? 
Kako naj bi zdravilo Bosatria delovalo?
Bosatria was expected to be used in patients who lack a gene called the ‘FIP1L1-PDGRF fusion gene' to reduce or eliminate the need for the patients to be treated with corticosteroids (steroids used to treat the disease) and to reduce the level of eosinophils in the blood. 
Zdravilo Bosatria naj bi se uporabljajo pri bolnikih, ki nimajo gena, imenovanega „fuzijski gen FIP1L1PDGRF“, za zmanjšanje ali odpravo potrebe po zdravljenju s kortikosteroidi (steroidi, ki so se uporabljali za zdravljenje te bolezni) in zmanjšanje števila eozinofilcev v krvi.
Based on the review of the data and the company's response to the CHMP lists of questions, at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Bosatria could not have been approved for the treatment of adults with hypereosinophilic syndrome who lack the FIP1L1-PDGRF fusion gene, to reduce or eliminate the need for corticosteroid therapy and to reduce blood eosinophil counts. 
Na podlagi pregleda podatkov in odgovorov družbe na seznam vprašanj, ki jih je do umika vloge zastavil CHMP, je Odbor izrazil določene zadržke in je začasno menil, da zdravila Bosatria ni mogoče odobriti za zdravljenje odraslih bolnikov s hipereozinofilnim sindromom in brez fuzijskega gena FIP1L1-PDGRF za zmanjšanje ali odpravo potrebe po zdravljenju s kortikosteroidi in zmanjšanje števila eozinofilcev v krvi.
Therefore, at the time of the withdrawal, the CHMP was of the opinion that the benefits of Bosatria did not outweigh its risks in the treatment of adults with hypereosinophilic syndrome who lack the FIP1L1-PDGRF fusion gene, to reduce or eliminate the need for corticosteroid therapy and to reduce blood eosinophil counts. 
CHMP je v času umika menil, da koristi zdravila Bosatria ne odtehtajo z njim povezanih tveganj za zdravljenje odraslih bolnikov s hipereozinofilnim sindromom in brez fuzijskega gena FIP1L1-PDGRF za zmanjšanje ali odpravo potrebe po zdravljenju s kortikosteroidi in zmanjšanje števila eozinofilcev v krvi.
The potential risk for humans is unknown. 
Morebitno tveganje za ljudi ni znano.
Efficacy was evaluated in 2,928 patients. 
Učinkovitost so preučevali pri 2928 bolnicah.
It may harm them, 
To so lahko znaki poškodbe ušesnih kosti,
- Choose one day of the month that will be easy to remember. 
- Izberite dan v mesecu, ki si ga boste zlahka zapomnili.
It's important to follow these instructions carefully. 
Pomembno je, da natančno upoštevate ta navodila.
- If your kidneys are not functioning normally. 
- Če vaše ledvice ne delujejo normalno.
No data are available. 
Podatki niso na voljo.
Quality of Life * 
kakovost življenja*
Please consult your doctor. 
Prosimo, posvetujte se s svojim zdravnikom.
A healthy lifestyle will also help you to get the most benefit from your treatment. 
Zdrav način življenja vam bo prav tako pomagal, da bo vaše zdravljenje čim bolj uspešno.
You can drink water but no other drinks. 
Lahko pijete vodo, vendar ne drugih pijač.
Choose the date that best fits your routine. 
Izberite datum, ki najbolje ustreza vašim navadam.
2 years 
2 leti
• feeling tired and exhausted 
• občutek utrujenosti in izčrpanosti,
Do not let the tablet dissolve in your mouth. 
Ne pustite, da se tableta raztopi v ustih.
Attention should also be paid to the possible existence of simultaneous hypomagnesaemia. 
Pozorni moramo biti tudi na možnost sočasno obstoječe hipomagneziemije.
No indication of carcinogenic potential was observed. 
Kancerogenega potenciala niso opazili.
This was demonstrated in both the primary analysis at one year and in the confirmatory analysis at two years endpoint (Table 2). 
To so dokazali v primarni analizi po enem letu in v potrditveni analizi v končni točki po dveh letih (Preglednica 2).
Do not take a double dose to make up for a forgotten dose. 
Ne vzemite dvojnega odmerka, da bi nadomestili pozabljeno tableto.
The release of pharmaceuticals in the environment should be minimized. 
Izpust farmacevtskih izdelkov v okolje je treba zmanjšati na najnižjo možno raven.
Instead, consult your calendar and find out when your next scheduled dose is. 
Namesto tega poglejte v vaš koledar, kdaj je naslednji načrtovani odmerek.
The results from these trials are summarised below. 
Izsledki teh preskušanj so povzeti spodaj.
Note down the date you take your tablet. 
Zapišite si datum, ko ste vzeli tableto.
In table 1 a complete list of known adverse reactions is presented. 
V preglednici 1 je celoten seznam znanih neželenih učinkov.
Poor healing of these fractures has also been reported. 
Poročali so tudi o slabem celjenju teh zlomov.
Especially: 
Še posebno:
If you wear dentures you should make sure these fit properly. 
Če nosite protezo, morate zagotoviti, da se vam dobro prilega.
There are few data available on patients of African origin. 
Na voljo je zelo malo podatkov o bolnikih afriškega izvora.
Patients should not take two tablets within the same week. 
Bolnik ne sme vzeti dveh tablet v enem tednu.
If you are taking a tablet every other day or once a week, ask your doctor or pharmacist for advice. 
Če jemljete tableto vsak drugi dan ali enkrat na teden, vprašajte vašega zdravnika ali farmacevta za nasvet.
• It also helps to prevent other bone problems that may need surgery or radiotherapy. 
• Pomaga preprečiti druge težave s kostmi, zaradi česar bi potrebovali operacijo ali radioterapijo.
You can choose either the same date (such as the 1st of each month) or the same day (such as the first Sunday of each month) to take your Ibandronic Acid Teva tablet. 
Izberite isti datum (na primer prvega v mesecu) ali isti dan (na primer prvo nedeljo vsakega meseca), ko boste vzeli tableto Ibandronska kislina Teva.
Lumbar spine L2-L4 
MKG ledvene hrbtenice L2-L4
• Take your tablet with a full glass of water only (about 200 mL). 
• Vzemite tableto samo s polnim kozarcem pitne vode (približno 200 ml).
How much to take 
Koliko zdravila morate vzeti
Multiple events were therefore, counted only once in any given 12 week period for the purposes of the analysis. 
Večkratne dogodke so za namen analize upoštevali samo enkrat v katerem koli 12-tedenskem obdobju.
The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch. 
V natisnjenem navodilu za uporabo zdravila mora biti navedeno ime in naslov izdelovalca odgovornega za sproščanje zadevne serije.
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: 
Za nadaljnje informacije o tem zdravilu se lahko obrnete na lokalno predstavništvo imetnika dovoljenja za promet z zdravilom:
• serious, potentially life-threatening allergic reaction 
• resna, možno življenjsko ogrožajoča alergijska reakcija,
Summary of the safety profile 
Povzetek varnostnega profila zdravila
When taken 30 minutes before a meal, the reduction in bioavailability is approximately 30%. 
Pri jemanju 30 minut pred obrokom je zmanjšanje biološke uporabnosti približno 30odstotno.
Water with a high concentration of calcium should not be used. 
Vode z visoko koncentracijo kalcija se ne sme uporabljati.
It is important to try and prevent ONJ developing as it is a painful condition that can be difficult to treat. 
Pomembno je, da nastanek osteonekroze čeljustnic poskusimo preprečiti, saj je to boleče stanje, ki ga je težko zdraviti.
• It helps to prevent your bones from breaking (fractures). 
• Pomaga preprečiti zlome (frakture) kosti.
Teva Czech Industries s.r.o Ostravska 29/305, 747 70 Opava-Komarov Czech Republic 
Teva Czech Industries s.r.o Ostravska 29/305, 747 70 Opava-Komarov
- If you can't stand or sit upright for at least one hour (60 minutes) at a time. 
- če ne morete stati ali pokončno sedeti vsaj eno uro (60 minut) naenkrat.
Efficacy results are summarised in Table 2. 
Rezultati učinkovitosti so povzeti v preglednici 2.
In growing rats, there was no evidence of impaired mineralization even at doses greater than 5,000 times the dose required for osteoporosis treatment. 
Pri rastočih podganah niso našli dokazov o motnji mineralizacije tudi pri odmerkih, ki so bili 5000-krat večji od odmerkov, potrebnih za zdravljenje osteoporoze.
The extent of absorption is impaired when taken together with food or beverages (other than water). 
Obseg absorpcije je pri sočasnem jemanju s hrano ali pijačo (razen pitne vode) zmanjšan.
Month 3 
Mesec 3
Do not take your tablet with any drink other than water. 
Tablete ne vzemite z nobeno drugo pijačo razen vode.
- After you've waited for an hour, you can have your first food and drink of the day. 
- Ko ste počakali eno uro, lahko zaužijete prvo hrano ali pijačo.
In order to reduce the risk of developing osteonecrosis of the jaw, there are some precautions you should take. 
Da bi zmanjšali tveganje za razvoj osteonekroze čeljustnic, morate upoštevati nekatere previdnostne ukrepe.
Manufacturer: 
Izdelovalci:
You can help stop this happening by doing the following: 
To lahko preprečite z upoštevanjem spodnjih navodil:
The serum calcium level may fall to hypocalcaemic values. 
Serumske koncentracije kalcija lahko padejo do hipokalciemičnih vrednosti.
• severe adverse skin reactions. 
• hude neželene kožne reakcije.
All patients received 500 mg calcium and 400 IU vitamin D daily. 
Vse bolnice so prejemale 500 mg kalcija in 400 i.e. vitamina D dnevno.
Treatment was most frequently associated with a decrease in serum calcium to below normal range (hypocalcaemia), followed by dyspepsia. 
Zdravljenje je bilo najpogosteje povezano z znižanjem serumskega kalcija na pod spodnjo mejo normale (hipokalciemija), sledi dispepsija.
At the menopause, a woman's ovaries stop producing the female hormone, oestrogen, which helps to keep her skeleton healthy. 
V menopavzi jajčniki prenehajo proizvajati ženski hormon estrogen, ki ženskam pomaga ohranjati zdravo okostje.
Pharmacokinetics in special clinical situations 
Farmakokinetika v posebnih kliničnih razmerah
Once you've eaten, it's OK to lie down if you wish, and to take any other medication you need. 
Ko pojeste, se po želji lahko uležete in vzamete kakšno drugo zdravilo, če ga potrebujete.
Other disturbances of bone and mineral metabolism should also be effectively treated. 
Učinkovito je treba zdraviti tudi druge motnje kosti in presnove mineralov.
- If you have, or had in the past low blood calcium. 
- če imate ali ste v preteklosti imeli nizko raven kalcija v krvi.
Talk to a nurse or doctor if any effects become troublesome or last more than a couple of days 
Obrnite se na medicinsko sestro ali zdravnika, če simptomi postanejo moteči ali trajajo več kot nekaj dni.
The most frequently reported adverse reactions are arthralgia and influenza-like symptoms. 
Najpogosteje poročani neželeni učinki so bili artralgija in simptomi, podobni gripi.
Both daily and intermittent (with prolonged dose-free intervals) long-term administration in rats, dogs and monkeys was associated with formation of new bone of normal quality and maintained or increased mechanical strength even at doses in the toxic range. 
Tako dnevno kot intermitentno (s podaljšanimi premori brez odmerkov) dolgotrajno dajanje zdravila podganam, psom in opicam je bilo povezano s tvorbo nove kosti normalne kakovosti, mehanska moč pa se je ohranila ali celo povečala tudi pri toksičnih odmerkih.
- Swallow your tablet whole, - do not chew it, crush it or let it dissolve in your mouth. 
- Pogoltnite celo tableto - ne smete je žvečiti, zdrobiti ali pustiti, da bi se vam raztopila v ustih.
Possible risk factors for osteonecrosis of the external auditory canal include steroid use and chemotherapy and/or local risk factors such as infection or trauma. 
Možni dejavniki tveganja za osteonekrozo zunanjega sluhovoda vključujejo uporabo steroidov, kemoterapijo in/ali lokalne dejavnike tveganja, kot so okužbe ali poškodbe.
You may be having a serious, potentially life threatening allergic reaction. 
Lahko imate resno, morda življenjsko ogrožajočo alergijsko reakcijo;
Do not take your tablet with water with a high concentration of calcium, fruit juice or any other drinks. 
Tablete ne vzemite z vodo z visoko vsebnostjo kalcija, sadnim sokom ali katero koli drugo pijačo.
The vertebral fracture risk reduction was very consistent with that seen in the overall population. 
Zmanjšanje relativnega tveganja za zlome vretenc je bilo zelo skladno s tistim, ki so ga opazili v celotni populaciji.